IRIS
PATRONO, Carlo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.137
AS - Asia 2.231
EU - Europa 2.024
SA - Sud America 164
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 7.593
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.085
SG - Singapore 873
CN - Cina 644
UA - Ucraina 370
IE - Irlanda 312
TR - Turchia 300
SE - Svezia 259
RU - Federazione Russa 246
GB - Regno Unito 226
DE - Germania 179
VN - Vietnam 176
FR - Francia 168
BR - Brasile 135
IT - Italia 115
IN - India 111
FI - Finlandia 91
HK - Hong Kong 27
MX - Messico 22
CA - Canada 20
IQ - Iraq 16
AR - Argentina 14
PL - Polonia 14
ZA - Sudafrica 14
NL - Olanda 10
BD - Bangladesh 9
IL - Israele 9
JP - Giappone 9
ID - Indonesia 8
BE - Belgio 7
SA - Arabia Saudita 7
AT - Austria 5
CZ - Repubblica Ceca 5
EG - Egitto 5
ES - Italia 5
EU - Europa 5
PH - Filippine 5
UY - Uruguay 5
IR - Iran 4
KR - Corea 4
PK - Pakistan 4
TW - Taiwan 4
VE - Venezuela 4
CL - Cile 3
DZ - Algeria 3
HN - Honduras 3
JO - Giordania 3
MA - Marocco 3
AU - Australia 2
BB - Barbados 2
KE - Kenya 2
KG - Kirghizistan 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
OM - Oman 2
QA - Qatar 2
RO - Romania 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EC - Ecuador 1
EE - Estonia 1
GD - Grenada 1
GE - Georgia 1
JM - Giamaica 1
KH - Cambogia 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MT - Malta 1
NO - Norvegia 1
NP - Nepal 1
PA - Panama 1
PY - Paraguay 1
RS - Serbia 1
TN - Tunisia 1
UZ - Uzbekistan 1
Totale 7.593
Salva come PNG Salva come JPEG
Città #
Singapore 657
Jacksonville 411
Chandler 365
San Jose 346
Dublin 310
Ashburn 196
Beijing 186
Southend 172
Izmir 147
Princeton 143
Dallas 127
Wilmington 105
Nanjing 102
Santa Clara 88
Los Angeles 86
Dearborn 75
Cambridge 67
Ho Chi Minh City 53
Buffalo 45
Munich 44
New York 44
The Dalles 42
Ann Arbor 41
Tongling 39
Hanoi 38
Nanchang 36
Moscow 35
Woodbridge 35
Altamura 29
Hong Kong 25
Shenyang 23
Kunming 21
Helsinki 19
Boardman 18
Jiaxing 18
Grevenbroich 17
Hebei 17
Houston 17
São Paulo 16
Changsha 15
Washington 15
Augusta 14
Hefei 13
Norwalk 13
Chieti 12
Council Bluffs 12
Redondo Beach 12
Tianjin 12
Johannesburg 11
Orem 11
Warsaw 11
Brooklyn 10
Haiphong 10
Hangzhou 10
San Mateo 10
Chicago 9
Da Nang 9
Falls Church 9
Frankfurt am Main 9
Tokyo 9
Baghdad 8
Boston 8
Chennai 8
Lanzhou 8
Orange 8
Seattle 8
Atlanta 7
Brussels 7
Jinan 7
Leawood 7
Montreal 7
Shanghai 7
Lucca 6
Phoenix 6
Poplar 6
Querétaro 6
San Francisco 6
Stockholm 6
Toronto 6
Amsterdam 5
Belo Horizonte 5
Denver 5
Manchester 5
Mexico City 5
Turku 5
Zhengzhou 5
Brno 4
Hackney 4
Hải Dương 4
Milan 4
Montevideo 4
Nha Trang 4
Padua 4
Queens 4
Seoul 4
Taiyuan 4
Tavagnacco 4
Bandung 3
Biên Hòa 3
Bắc Ninh 3
Totale 4.711
Salva come PNG Salva come JPEG
Nome #
Low-dose aspirin acetylates cyclooxygenase-1 in human colorectal mucosa: implications for the chemoprevention of colorectal cancer. 184
Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration. 173
Platelet-specific deletion of cyclooxygenase-1 ameliorates dextran sulfate sodium-induced colitis in mice. 160
Variability in the Recovery Rate of Platelet Cyclooxygenase Activity During Chronic Therapy With Low-Dose Aspirin in Type 2 Diabetes. 160
Platelet Cyclooxygenase Inhibition by Low-Dose Aspirin Is Not Reflected Consistently by Platelet Function Assays. Implications for Aspirin "Resistance" 152
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus 150
Determinants of the Variability in the Recovery Rate of Platelet Cyclooxygenase Activity during Chronic Therapy with Low-Dose Aspirin in Type 2 Diabetes 140
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays. implications for aspirin 'resistance'. 140
Thromboxane biosynthesis and pulmonary function in cystic fibrosis 135
Insulin resistance as a determinant of platelet activation in obese women. 129
Aspirin after acute myocardial infarction: a systematic approach to compare the hemostatic effects of three different doses. 129
Vitamin E inhibits enhanced F2 isoprostane biosynthesis in type IIA hypercholesterolemia 126
Cyclooxygenase-2 expression and inhibition in atherothrombosis. 124
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 124
Platelet Activation and Lipid Peroxidation in Patients With Acute Ischemic Stroke. 121
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 121
Aspirin, platelet inhibition and cancer prevention. 121
In vivo formation of 8-iso-prostaglandin f2alpha and platelet activation in diabetes mellitus: effects of improved metabolic control and vitamin E supplementation. 119
Platelet cyclooxygenase inhibition by low-dose aspirin is not reflected consistently by platelet function assays: implications for aspirin "resistance". 119
Immunological characterization uf urinary 8-epi-prostaglandin f2alfa excretion in man 118
Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina. 116
Platelets as a source of CD40 ligand in type 2 diabetes mellitus 116
Determinants of platelet activation in human essential hypertension. 116
Increased thromboxane production by monocyte prostaglandin endoperoxide synthase-2 in patients with acute myocardial infarction (pubbl. su Suppl. Circulation) 115
In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. 113
Differential Expression and Regulation of Cyclooxygenase Isozymes in Thymic Stromal Cells. 113
Determinants of platelet activation in Alzheimer's disease 113
Cyclooxygenase-2 polymorphism: putting a brake on the inflammatory response to vascular injury? 112
In vivo formation of 8-epi-prostaglandin F2alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation. (pubbl su Suppl Thromb Haemostas) 111
Postprandial hyperglycemia is an important determinant of platelet activation. evidence from biochemical measurements and pharmacological intervention with acarbose 111
Postprandial hyperglycemia is an important determinant of platelet activation in early type 2 diabetes mellitus. Evidence from biochemical measurements and pharmacological intervention with acarbose. 111
Effects of nabumetone on prostanoid biosynthesis in humans. 110
Insulin resistance as a determinant of platelet activation in obese women 110
Antiplatelet agents in the prevention of diabetic vascular complications 109
In vivo formation of 8-epi-prostaglandin F2alpha in increased in hypercholesterolemia. An aspirin-insensitive amplification mechanism of platelet activation (pubbl su Suppl Thromb Haemostas) 108
Mechanisms, consequences, and prevention of coronary graft failure 107
Increased thromboxane biosynthesis in essential thrombocythemia 106
Role of Platelet Activation in Dementia 106
Determinants of Thromboxane-Dependent Platelet Activation in Heart Failure. 106
Drugs, prostaglandins, and renal function. 105
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes 105
Determinants of Platelet Activation in Heart Failure. 105
Platelet activation in obese women: role of inflammation and oxidant stress. 104
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 104
Effects of Acarbose on in Vivo Markers of Oxidative Stress and Platelet Activation in Early Type 2 Diabetes. 103
Nutraceuticals in diabetes and metabolic syndrome. 100
Thromboxane and prostacyclin biosynthesis in heart failure of ischemic origin: effects of disease severity and aspirin treatment. 99
In vivo formation of 8-EPI-prostaglandin F2 alpha in diabetes mellitus. Effects of tight metabolic control and vitamin E supplementation 98
Cyclooxygenase-2 expression and inhibition in human monocytes 97
Determinants of Platelet Activation in Heart Failure. 96
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 95
Soluble CD40L as an indicator of platelet Activation in Heart Failure 95
Effects of vitamin E supplementation on F2-isoprostane and thromboxane biosynthesis in healthy cigarette smokers. 92
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 91
Abnormally high thromboxane biosynthesis in homozygous homocystinuria. Evidence for platelet involvement and probucol-sensitive mechanism 91
In vivo formation of 8-iso-prostaglandin F2a and aspirin-insensitive thromboxane biosynthesis in unstable angina 90
Homocysteine, methylenetetrahydrofolate reductase, folate status and atherothrombosis: A mechanistic and clinical perspective 88
In vivo formation of 8-isoprostaglandin F-2 alpha and platelet activation in diabetes mellitus. Effects of improved metabolic control and vitamin E supplementation 87
Insulin resistance as a determinant of platelet activation in obese women 87
Short term Vitamin E treatment normalizes LDL oxidative susceptibility in diabetic subjects. 86
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 86
Effects of the novel anti-inflammatory compounds, N-[2-(cyclohexyloxy)-4-nitrophenyl] methanesulphonamide (NS-398) and 5-methanesulphonamido-6-(2,4-difluorothiophenyl)-1-indanone (L-745,337), on the cyclo-oxygenase activity of human blood prosta-glandin endoperoxide synthases 83
Effects of successful weight loss or pioglitazone on thromboxane-dependent platelet activation in obese women 83
Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial 79
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism 78
Thromboxane biosynthesis and metabolism in relation to cardiovascular risk factors 76
Thromboxane biosynthesis in cardiovascular diseases 76
Oxidative Stress and Platelet Activation in Subjects with Moderate Hyperhomocysteinemia Due to MTHFR 677 C->T Polymorphism. 75
Fractional conversion of thromboxane B2 to urinary 11-dehydrothromboxane B2 in man 70
Increased thromboxane biosynthesis in type IIa hypercholesterolemia 67
In vivo platelet activation in diabetes mellitus 55
Off-pump coronary artery bypass grafting: 30 years of debate 48
Platelet activation, aspirin, and cancer: From basic science to clinical trials 3
Totale 7.751
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.410
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.410
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021100 0 0 0 0 0 0 0 0 0 70 10 20
2021/2022275 1 4 6 47 26 5 7 18 25 9 41 86
2022/2023989 81 129 80 98 89 211 57 62 125 13 19 25
2023/2024417 32 10 31 13 30 113 126 18 2 3 5 34
2024/20251.184 95 283 202 16 9 41 12 29 79 41 128 249
2025/20262.287 236 114 222 261 288 155 468 100 286 157 0 0
Totale 7.751